Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug authorized in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and adults . This functions as a prodrug, meaning https://apolisdexamfetamineprice209915.reflectblog.com/803929/vyvanse-in-canada-a-comprehensive-guide